Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Performance of the VenusP-ValveTM System in Patients with Native RVOT Dysfunction

NCT06010563 is registered in ClinicalTrials.gov with Venus MedTech (HangZhou) Inc. as lead sponsor.

NCT NCT06010563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06010563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Performance of the VenusP-ValveTM System in Patients with Native RVOT Dysfunction
Lead sponsor
Venus MedTech (HangZhou) Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
June 11, 2024
Completion date
August 30, 2034
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary regurgitation